Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China · Delayed Price · Currency is CNY 26.27
-0.85 (-3.13%)
Apr 21, 2026, 3:00 PM CST
Aurisco Pharmaceutical Market Cap
Aurisco Pharmaceutical has a market cap or net worth of 11.02 billion as of April 20, 2026. Its market cap has increased by 32.03% in one year.
Market Cap
11.02B
Enterprise Value
11.01B
Revenue
1.70B
Ranking
n/a
PE Ratio
24.65
Stock Price
26.27
Market Cap Chart
Since September 21, 2020, Aurisco Pharmaceutical's market cap has increased from 4.83B to 11.02B, an increase of 127.97%. That is a compound annual growth rate of 15.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 11.02B | 8.26% |
| Dec 31, 2025 | 10.18B | 18.61% |
| Dec 31, 2024 | 8.58B | -18.20% |
| Dec 29, 2023 | 10.49B | 4.58% |
| Dec 30, 2022 | 10.03B | 13.58% |
| Dec 31, 2021 | 8.83B | 38.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InventisBio | 12.76B |
| Pacific Shuanglin Bio-pharmacy | 12.27B |
| Hualan Biological Vaccine | 11.85B |
| Chengdu Olymvax Biopharmaceuticals | 11.81B |
| Chengdu Easton Biopharmaceuticals | 11.66B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 11.51B |
| Chongqing Genrix Biopharmaceutical | 11.41B |
| Beijing Hotgen Biotech | 10.92B |